Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 225.
[40-60] [0 - 20][0 - 50][60-80]

Ident.	Authors (with country if any)	Title
000297 (2002)	Y. Tsuboi [États-Unis] ; M. Baker ; M L Hutton ; R J Uitti ; O. Rascol ; M-B Delisle ; X. Soulages ; J R Murrell ; B. Ghetti ; M. Yasuda ; O. Komure ; S. Kuno ; K. Arima ; N. Sunohara ; T. Kobayashi ; Y. Mizuno ; Z K Wszolek	Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).
000305 (2003)	Patrice Péran [France] ; Olivier Rascol ; Jean-François Démonet ; Pierre Celsis ; Jean-Luc Nespoulous ; Bruno Dubois ; Dominique Cardebat	Deficit of verb generation in nondemented patients with Parkinson's disease.
000308 (2003)	Serge Pinto [France] ; Michèle Gentil ; Valérie Fraix ; Alim-Louis Benabid ; Pierre Pollak	Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
000313 (2003)	Kathy Dujardin [France] ; Luc Defebvre [France] ; Pierre Krystkowiak ; Jean François Degreef ; Alain Destée [France]	Executive function differences in multiple system atrophy and Parkinson's disease.
000316 (2003)	Olivier Rascol ; Pierre Payoux ; Fabienne Ory ; Joaquim J. Ferreira ; Christine Brefel-Courbon ; Jean-Louis Montastruc	Limitations of current Parkinson's disease therapy.
000326 (2003)	Aurélie Funkiewiez [France] ; Claire Ardouin ; Paul Krack ; Valérie Fraix ; Nadège Van Blercom ; Jing Xie ; Elena Moro ; Alim-Louis Benabid ; Pierre Pollak	Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
000330 (2003)	Erwan Bézard [France] ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre Sokoloff	Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.
000347 (2003)	Olivier Rascol [France]	Monoamine oxidase inhibitors--is it time to up the TEMPO?
000356 (2003)	Ebba Lohmann [France] ; Magali Periquet ; Vincenzo Bonifati ; Nick W. Wood ; Giuseppe De Michele ; Anne-Marie Bonnet ; Valérie Fraix ; Emmanuel Broussolle ; Martin W I M. Horstink ; Marie Vidailhet ; Patrice Verpillat ; Thomas Gasser ; David Nicholl ; Hélio Teive ; Salmo Raskin ; Olivier Rascol ; Alain Destée [France] ; Merle Ruberg ; Francesca Gasparini ; Giuseppe Meco ; Yves Agid [France] ; Alexandra Durr ; Alexis Brice	How much phenotypic variation can be attributed to parkin genotype?
000359 (2003)	Julie Hudry [France] ; Stéphane Thobois ; Emmanuel Broussolle ; Patrice Adeleine ; Jean-Pierre Royet	Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease.
000364 (2003)	X. Drouot [France] ; S. Moutereau ; J P Nguyen ; J P Lefaucheur ; A. Créange ; P. Remy ; F. Goldenberg ; M P D'Ortho	Low levels of ventricular CSF orexin/hypocretin in advanced PD.
000366 (2003)		Entacapone/levodopa/carbidopa combination tablet: Stalevo.
000390 (2003)	Paul Krack [France] ; Alina Batir ; Nadège Van Blercom ; Stephan Chabardes ; Valérie Fraix ; Claire Ardouin ; Adnan Koudsie ; Patricia Dowsey Limousin ; Abdelhamid Benazzouz ; Jean François Lebas ; Alim-Louis Benabid ; Pierre Pollak	Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
000391 (2003)	D. Devos [France] ; E. Labyt ; F. Cassim ; J L Bourriez ; N. Reyns ; G. Touzet ; S. Blond ; J D Guieu ; P. Derambure ; A. Destée ; L. Defebvre	Subthalamic stimulation influences postmovement cortical somatosensory processing in Parkinson's disease.
000403 (2003)	D. Devos [France] ; E. Labyt ; P. Derambure ; J L Bourriez ; F. Cassim ; J D Guieu ; A. Destée ; L. Defebvre	Effect of L-Dopa on the pattern of movement-related (de)synchronisation in advanced Parkinson's disease.
000406 (2003)	N V Fedorova	[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
000407 (2004)	D. Devos [France] ; E. Labyt ; P. Derambure ; J L Bourriez ; F. Cassim ; N. Reyns ; S. Blond ; J D Guieu ; A. Destée ; L. Defebvre	Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
000418 (2004)	F. Durif [France] ; B. Debilly ; M. Galitzky ; D. Morand ; F. Viallet ; M. Borg ; S. Thobois ; E. Broussolle ; O. Rascol	Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
000427 (2004)	David Maltête [France] ; Soledad Navarro ; Marie-Laure Welter ; Sabine Roche ; Anne-Marie Bonnet ; Jean-Luc Houeto ; Valérie Mesnage ; Bernard Pidoux ; Didier Dormont ; Philippe Cornu ; Yves Agid [France]	Subthalamic stimulation in Parkinson disease: with or without anesthesia?
000431 (2004)	K. Ashkan [France] ; B. Wallace ; B A Bell ; A L Benabid	Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 1993-2003: where are we 10 years on?
000450 (2004)	Günter U. Höglinger [France] ; Pamela Rizk ; Marie P. Muriel ; Charles Duyckaerts ; Wolfgang H. Oertel ; Isabelle Caille ; Etienne C. Hirsch	Dopamine depletion impairs precursor cell proliferation in Parkinson disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024